Core Viewpoint - Huaxia Eye Hospital (301267) emphasizes its commitment to providing high-quality and cutting-edge ophthalmic medical services while closely monitoring the development and application of new technologies in the ophthalmic medical industry [1] Company Summary - The company’s main business focuses on ophthalmic medical services [1] - It actively introduces advanced equipment and diagnostic technologies from the industry [1] - The goal is to offer superior and innovative diagnostic and treatment services [1] Industry Summary - The company is attentive to the advancements in the ophthalmic medical industry [1] - There is a focus on the application of new technologies within the sector [1]

Group 1 - The stock price of Aier Eye Hospital closed at 13.24 yuan on August 20, 2025, reflecting a 1.22% increase from the previous trading day, with a trading volume of 1.389 billion yuan and a fluctuation of 2.52% [1] - Aier Eye Hospital is a leading ophthalmology medical chain in China, offering services in refractive surgery, cataract treatment, and vision care [1] - The Shanghai Aier Eye Hospital has introduced a plasma coating care technology that can repair scratched corneal reshaping lenses (OK lenses), effectively reducing the cost for parents to replace lenses. This technology cleans the lens surface using low-temperature argon plasma, achieving a sterilization rate of over 90%, and has already helped over a hundred children extend the lifespan of their lenses in outpatient settings [1] Group 2 - On August 20, Aier Eye Hospital saw a net inflow of 23.5613 million yuan in main funds, while there was a net outflow of 1.79 billion yuan over the past five days [2]